Drug | Dose | n | Epidermal Injury | Eosinophil Infiltration | ||
---|---|---|---|---|---|---|
Crust formation | Vacuolation | Epidermis | Crust | |||
mg/kg, p.o. | ||||||
Control | 11 | 2.7 ± 0.2 | 2.7 ± 0.2 | 2.2 ± 0.1 | 2.9 ± 0.3 | |
TAK-427 | 0.3 | 12 | 2.5 ± 0.2 | 2.3 ± 0.1 | 1.8 ± 0.1 | 2.9 ± 0.3 |
3 | 12 | 2.3 ± 0.2 | 2.4 ± 0.3 | 1.8 ± 0.2 | 1.9 ± 0.3 | |
30 | 12 | 2.3 ± 0.1 | 2.1 ± 0.1 | 1.6 ± 0.13-150 | 1.7 ± 0.33-150 | |
Control | 10 | 3.0 ± 0.3 | 3.0 ± 0.2 | 2.2 ± 0.1 | 2.4 ± 0.2 | |
Dexamethasone | 1 | 10 | 2.6 ± 0.2 | 2.5 ± 0.2 | 2.1 ± 0.1 | 2.3 ± 0.2 |
3 | 10 | 2.9 ± 0.2 | 2.5 ± 0.2 | 2.1 ± 0.1 | 2.4 ± 0.2 | |
10 | 10 | 2.4 ± 0.2 | 2.1 ± 0.33-150 | 2.0 ± 0.0 | 2.3 ± 0.2 |
OVA was applied with a patch to the shaved flank of epicutaneously sensitized guinea pigs. Drugs were administered p.o. twice daily for 3 days beginning the day before antigen challenge. Skin specimens were collected 48 h after antigen challenge. The histological preparations were scored on a scale of 1 to 4. Results are expressed as means ± S.E.M.
↵3-150 P < 0.05 vs. control (Dunnett's test).